4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-056198
EVP, Chief Development Officer bought 25,000 shares at $1.09 ($27,250)
From the SEC's structured data for this filing
Trades in this filing
Forbes William P · EVP, Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-17 | Purchase : show line 1 in the form | +25,000 | $1.09 | $27,250 | 79,000 | D |
| Open-market purchases · 25,000 sh · avg $1.09 · $27,250 | ||||||
Loading xslF345X05/doc4.xml…